Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
Author: Beverly Thomassian, RN, MPH, CDCES, BC-ADM CEO & President, DiabetesEd Services For decades, healthcare professionals have cared for individuals diagnosed with Polycystic Ovary Syndrome (PCOS), a condition that affects … Continue reading From PCOS to PMOS: Why the Renaming of PCOS Matters
A 42-year-old woman with type 2 diabetes presents for follow-up. She reports trying to lose weight by “cutting carbs,” but admits she often skips meals during the day and overeats … Continue reading Question of the Week | Meal Skipping and Postprandial Hyperglycemia
Celebrations are in order! June is Pride Month – a time to honor diversity, inclusion, and the freedom to be authentically ourselves. It’s also a special month for another reason … Continue reading June 2026 e-News | PCOS Renamed & PocketCard Updates
For last week’s practice question, we quizzed participants on A1C 7.4% & struggling with hypoglycemia. 83% of respondents chose the best answer. We want to clarify and share this important … Continue reading Rationale of the Week | A1C 7.4% & Struggling with Hypoglycemia
Author: Sarah Hormachea, MS, RD, CDCES, BC-ADMDiabetes Care and Education, LLC If you subscribe to the CBDCE listserv, you probably noticed a recent email announcing exploration of a new credential … Continue reading Beyond the CDCES: A New Credential for Diabetes Support Staff Is on the Horizon
JL has T2DM, and heart failure with preserved ejection fraction (HFpEF). Is currently on Metformin 1000mg BID and empagliflozin 25mg daily. Their A1C is 8.1%. Which agent should be added … Continue reading Question of the Week | What’s the best medication for HFpEF?
For last week’s practice question, we quizzed participants on who would most benefit from metformin therapy. 63.26% of respondents chose the best answer. We want to clarify and share this … Continue reading Rationale of the Week | Who would most benefit from metformin therapy?
A 16-year-old with Type 1 Diabetes uses a CGM and has a Time in Range (70-180 mg/dL) of 72%, but their GMI (Glucose Management Indicator) is 7.4% and they report … Continue reading Question of the Week | A1C 7.4% & Struggling with Hypoglycemia